The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1

다국어 초록 (Multilingual Abstract)

Purpose: The goal of this study was to explore the effects of hsa-let-7g on cell proliferation and apoptosis, and elucidate its role inlung cancer development.
Materials and Methods: The expression levels of has-let-7g and HOXB1 in tissues and cells were measured by qRT-PCR. An inhibitorof hsa-let-7g or one targeting a control messenger RNA were transfected into A549 and H1944 lung cancer cells, and the effects ofhsa-let-7g dysregulation on cell viability and apoptosis were analyzed using CCK-8 and apoptosis detection assays. HOXB1 was confirmedas the target gene of hsa-let-7g, based on luciferase reporter assay results. The relationship between hsa-let-7g and HOXB1was confirmed by co-transfection of inhibitors of hsa-let-7g and HOXB1 followed by Western blot, CCK-8, and apoptosis detectionassays.
Results: We observed high expression of hsa-let-7g in lung cancer tissues compared to the corresponding normal tissues, andgenerally higher expression of hsa-let-7g in patients with advanced tumor classification. The results of CCK-8 and apoptosis detectionexperiments showed that the inhibition of hsa-let-7g significantly inhibited proliferation of A549 and H1944 cells, but also promotedapoptosis. HOXB1 is a specific target of hsa-let-7g, and downregulation of HOXB1 in lung cancer cells reversed the suppressiveeffects caused by knocking down hsa-let-7g.
Conclusion: These data collectively suggest that the expression of hsa-let-7g inhibits lung cancer cells apoptosis and promotesproliferation by down-regulating HOXB1. The results from this study demonstrate the potential of hsa-let-7g/HOXB1 axis as atherapeutic target for the treatment of lung cancer.

참고문헌 (Reference)

1 Del Vescovo V, "microRNA and lung cancer" 889 : 153-177, 2015

2 Li J, "miRNA 1284 inhibits cell growth and induces apoptosis of lung cancer cells" 16 : 3049-3054, 2017

3 Xu G, "miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2" 443 : 151-157, 2018

4 Li H, "miR-1254 promotes lung cancer cell proliferation by targeting SFRP1" 92 : 913-918, 2017

5 Cech TR, "The noncoding RNA revolution-trashing old rules to forge new ones" 157 : 77-94, 2014

6 Morgan R, "Targeting the HOX/PBX dimer in breast cancer" 136 : 389-398, 2012

7 Dimitrova N, "Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development" 6 : 188-201, 2016

8 Guazzi S, "Regulatory interactions between the human HOXB1, HOXB2, and HOXB3 proteins and the upstream sequence of the Otx2 gene in embryonal carcinoma cells" 273 : 11092-11099, 1998

9 Nakajima G, "Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer" 3 : 317-324, 2006

10 Yang Y, "MicroRNA-218functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis" 16 : 141-, 2017

11 Rupaimoole R, "MicroRNA therapeutics : towards a new era for the management of cancer and other diseases" 16 : 203-222, 2017

12 Wang L, "MicroRNA let-7g directly targets forkhead Box C2(FOXC2)to modulate bone metastasis in breast cancer" 12 : 157-162, 2017

13 Tafrihi M, "MiRNAs : biology, biogenesis, their web-based tools, and databases" 8 : 4-27, 2019

14 Woodard GA, "Lung cancer staging and prognosis" 170 : 47-75, 2016

15 Nasim F, "Lung cancer" 103 : 463-473, 2019

16 Martens-Uzunova ES, "Long noncoding RNA in prostate, bladder, and kidney cancer" 65 : 1140-1151, 2014

17 Zhou JL, "Hsa-let-7g promotes osteosarcoma by reducing HOXB1 to activate NF-kB pathway" 109 : 2335-2341, 2019

18 Hu H, "Hsa-let-7g miRNA regulates the antitumor effects of gastric cancer cells under oxidative stress through the expression of DDR genes" 40 : 329-338, 2015

19 Lan FF, "Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A)" 128 : 319-331, 2011

20 Roux M, "Hoxb1regulates proliferation and differentiation of second heart field progenitors in pharyngeal mesoderm and genetically interacts with Hoxa1 during cardiac outflow tract development" 406 : 247-258, 2015

21 Arenkiel BR, "Hoxb1 functions in both motoneurons and in tissues of the periphery to establish and maintain the proper neuronal circuitry" 18 : 1539-1552, 2004

22 Roux M, "Hoxa1 and Hoxb1 are required for pharyngeal arch artery development" 143 : 1-8, 2017

23 Han L, "HOXB1 is a tumor suppressor gene regulated by miR-3175 in glioma" 10 : e0142387-, 2015

24 López R, "HOXB homeobox gene expression in cervical carcinoma" 16 : 329-335, 2006

25 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018

26 Jiang LP, "Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer" 12 : 1105-1115, 2016

27 Siegel RL, "Cancer statistics, 2019" 69 : 7-34, 2019

28 Hu H, "A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD" 10 : 1641-1649, 2015

29 Hu X, "A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer" 26 : 344-357, 2014

30 Salmena L, "A ceRNA hypothesis : the Rosetta Stone of a hidden RNA language" 146 : 353-358, 2011